Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-MYCOPHENOLIC ACID | 360MG | TABLET (ENTERIC-COATED) | Resolved | 2021-03-26 | 2021-04-12 | 136409 |
APO-MYCOPHENOLIC ACID | 360MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-11 | 2021-07-26 | 140777 |
APO-MYCOPHENOLIC ACID | 180MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-18 | 2021-07-26 | 141247 |
APO-MYCOPHENOLIC ACID | 180MG | TABLET (ENTERIC-COATED) | Resolved | 2022-08-12 | 2023-01-13 | 166604 |
APO-MYCOPHENOLIC ACID | 360MG | TABLET (ENTERIC-COATED) | Resolved | 2022-11-04 | 2022-12-09 | 173823 |
APO-MYCOPHENOLIC ACID | 360MG | TABLET (ENTERIC-COATED) | Actual shortage | 2024-04-26 | 2024-04-26 | 226309 |
APO-NADOLOL | 40MG | TABLET | Resolved | 2022-09-30 | 2022-11-20 | 170801 |
APO-NADOLOL | 40MG | TABLET | Resolved | 2023-11-17 | 2024-01-26 | 210715 |
APO-NADOLOL | 80MG | TABLET | Resolved | 2023-12-08 | 2024-01-26 | 212919 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2017-10-11 | 2017-10-25 | 25299 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2017-11-28 | 2018-01-16 | 31016 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2018-08-21 | 2018-09-28 | 58594 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2018-11-21 | 2019-02-01 | 67404 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2019-08-07 | 2019-08-19 | 91091 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2020-04-06 | 2020-05-04 | 111060 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2021-02-12 | 2021-03-15 | 133991 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2021-05-28 | 2021-07-09 | 140075 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2021-08-13 | 2021-08-31 | 144142 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2023-01-06 | 2023-03-30 | 180119 |
APO-NAPRO-NA | 275MG | TABLET | Resolved | 2018-05-15 | 2018-10-05 | 49499 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | 250MG 62.5MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4906 |
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60246 |
APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
APO-AMOXI SUGAR FREE | 250MG | POWDER FOR SUSPENSION | Discontinued | 2020-06-22 | 2020-06-22 | 118526 |
APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
APO-ATENOL TAB 100MG | 100MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60261 |
APO-ATENOL TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60267 |
APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |
APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |
APO-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-11-09 | 60282 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
APO-BICALUTAMIDE | 50MG | TABLET | Discontinued | 2022-03-25 | 2022-05-13 | 157376 |
APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |